Comparative effectiveness

Every post on comparative effectiveness, newest first.

Posts

StudiesOct 28, 20264 min read
Weight-loss surgery beat tirzepatide in one diverse cohort
Three new reports compared tirzepatide with surgery and semaglutide, and reviewed its mood safety. The weight-loss finding was the clearest.

Compound pages

The evergreen research summaries these posts build on.

TirzepatideDual GIP/GLP-1 receptor agonist for weight loss and glycemic control.DulaglutideOnce-weekly GLP-1 agonist for type 2 diabetes and heart-risk reduction.LiraglutideA once-daily GLP-1 injection approved for weight loss and diabetes.CagrilintideOnce-weekly investigational amylin analogue for weight management.